Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorian de Moura Rodrigues

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cells|November 11, 2022
STING Targeting in Lung DiseasesDorian de Moura Rodrigues, Norinne Lacerda-Queiroz, Isabelle Couillin, et al.
Frontiers in Immunology|October 16, 2023
Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell deathSandra Carignon, Dorian De Moura Rodrigues, David Gosset, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2025
Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammationLucija Leko, Darija Šimić, Timna Valera Martins, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cells|November 11, 2022
STING Targeting in Lung DiseasesDorian de Moura Rodrigues, Norinne Lacerda-Queiroz, Isabelle Couillin, et al.
Frontiers in Immunology|October 16, 2023
Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell deathSandra Carignon, Dorian De Moura Rodrigues, David Gosset, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2025
Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammationLucija Leko, Darija Šimić, Timna Valera Martins, et al.
Pageof 1